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A B S T R A C T
Altered GLP-1 secretion from L cells has been implicated in the development of type 2 diabetes mellitus and its
resolution following bariatric surgery. However, changes in L cell gene expression, which may form the basis for
altered functionality after high fat diet (HFD) or bariatric surgery, have either not been investigated or have
given conﬂicting results. We developed a gcg-DTR-eGFP reporter mouse to isolate ileal and colonic L cells from
HFD fed insulin resistant mice and mice showing improved glucose tolerance following vertical sleeve gas-
trectomy (VSG). Transcriptomic sequencing and identiﬁcation of genes diﬀerentially expressed in response to
HFD or VSG revealed small changes with HFD, primarily in immune related genes, but no regulation following
VSG. In contrast, large diﬀerences were observed between ileal and colonic L cells due to the diﬀerential ex-
pression of genes involved in nutrient transport and metabolism, reﬂecting to some extent the diﬀerences in the
surrounding epithelium. We showed that, in line with the gene expression data, colonic and ileal L cells exhibit
diﬀering GLP-1 responses to nutrients (glucose and the gly-sar dipeptide) and hormones (vasopressin). Thus, we
hypothesise that colonic and ileal L cells have diﬀerent physiological roles, with ileal L cells contributing more to
postprandial glucose homeostasis by responding to dietary nutrients and colonic cells responding more to non-
dietary stimulants.
1. Introduction
Enteroendocrine L cells are classically deﬁned as secreting glu-
cagon-like peptide-1 (GLP-1) and peptide tyrosine tyrosine (PYY), and
are enriched in the distal regions of the gastrointestinal (GI) tract [1].
GLP-1 plays an important role in postprandial glucose homeostasis as it
acts as an incretin hormone, promoting pancreatic glucose-dependent
insulin secretion, while also inhibiting gastric emptying and suppres-
sing appetite [2]. Recently, it has been shown that L cells co-express
several additional hormones and that upper small intestine (SI) L cells
are more similar to upper SI K cells, which classically express gastric
inhibitory peptide (GIP), than colonic L cells [3].
Postprandial GLP-1 secretion has been reported to be blunted in
obese and diabetic patients [4–6], which may contribute to the devel-
opment of type 2 diabetes mellitus (T2DM) [7], although this is not
consistently observed [8]. Currently it is unclear how the murine L cell
responds to high fat diet (HFD) and peripheral insulin resistance as L
cell density and marker gene expression have been reported to be both
increased [9,10] and decreased [11,12] after 2–16 weeks HFD. Bariatric
surgical techniques, including vertical sleeve gastrectomy (VSG), are
the most eﬃcacious treatment method for obesity and T2DM [13], re-
sulting in early improvements in metabolic parameters before weight
loss occurs [14]. These improvements are consistently associated with
increased postprandial circulating GLP-1 [15–17], resulting from in-
creased nutrient delivery to the distal gut. In addition, L cell density
may be increased [18] or unchanged [19] after VSG, and the nutrient
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sensitivity of the L cell may be aﬀected [20]. However, the contribution
of elevated postprandial GLP-1 to the improved metabolic phenotype is
debated [21–23]. GLP-1 mimetics have been recently introduced to the
clinic for the control of blood glucose in T2DM, as the incretin eﬀect is
preserved in T2DM patients, and for the treatment of obesity [24].
Targeting GLP-1 responses remains a viable treatment approach for
diabetic patients, but to date our understanding of L cells is limited,
especially the mechanisms underlying the changes seen during insulin
resistance and following bariatric surgery.
Here, we transcriptionally characterise ileal and colonic L cells and
epithelial cells to examine their role in the development of metabolic
disease and its resolution following bariatric surgery. Transcriptomic
characterisation following HFD and VSG was used to investigate the
mechanisms underlying changes in GLP-1 secretion under these con-
ditions and to determine if other L cell properties are also altered and
contribute to the metabolic phenotype. In addition, we examine the
diﬀerences in L cells between tissues, how the diﬀerences in L cells
reﬂect changes in the surrounding epithelium and the consequence of
these diﬀerences on the current paradigm of L cell function.
2. Experimental procedures
2.1. Materials
All chemicals were purchased from Sigma-Aldrich unless otherwise
speciﬁed.
2.2. Animals
2.2.1. gcg-DTR-eGFP mice
The new mouse strain gcg-DTR-eGFP was prepared using Red / ET
recombination technology (Gene Bridges) as described previously [25].
Brieﬂy, a cassette containing a primate heparin-binding epidermal
growth factor-like growth factor (HB-EGF, here diphtheria toxin re-
ceptor, DTR) / enhanced green ﬂuorescent protein (eGFP) fusion gene
and a polyA sequence combined with a neo / kana resistance cassette
ﬂanked by frt sites was ampliﬁed by PCR with primers providing
overhangs for a direct recombination into the gcg (Preproglucagon)
coding region of the murine gcg locus of the bacterial artiﬁcial chro-
mosome (BAC) RP23-343 C17 (BACPAC Resources Center) which
contains the mouse gcg genomic sequence. Importantly, all upstream
and downstream regulatory sequences were included in the construct.
The experimental procedures for preparation and puriﬁcation of the
ﬁnal BAC are described in detail by Johansson et al. [26]. Cloning
primers are listed in Supplementary Information Table 1 and schematic
representations of the constructs are depicted in Fig. 1A. Transgenic
mice were generated by pronuclear injection into C57BL/6 N oocytes
according to standard procedures [27]. Transgene copy number was
estimated to be one by comparing Ct values for a transgene speciﬁc
probe vs. a probe recognizing apolipoprotein B (apoB).
2.2.2. Animal procedures
All animal work was approved by the cantonal veterinary oﬃce of
Zurich. Mice were kept in grouped cages on a 12 / 12 h light/dark cycle
in a pathogen-free animal facility with ad libitum access to food and
water. Mice were kept on standard laboratory chow (#3436, Kliba
Nafag, composition: https://www.serlab.com/uploads/1/1/0/3/
110311153/3436_souris_et_ratentretien_extrudat.pdf) or placed on a
puriﬁed high fat diet (HFD) consisting of 60% calories from fat (#2127,
Kliba Nafag, composition: http://www.kliba-nafag.ch/neutral/
download/2127.pdf). For the tolerance tests, mice were fasted for 6 h
prior to either i.p. injection of 0.6 U/kg insulin (Actrapid, Novo
Nordisk) for the insulin tolerance test or intragastric gavage of 200 μl
Ensure Plus liquid diet (29.5% calories from fat, 53.8% from carbohy-
drate and 16.7% from protein) for the mixed meal tolerance test. Blood
glucose was measured from the tail vein using an Accu-Check Aviva
blood glucose monitor (Roche). Awake mice were scanned using the
EchoMRI 3-in-1 analyzer (EchoMRI™, Singapore and Houston) to assess
fat and lean mass. For determination of plasma GLP-1, mice were fasted
for 4 h prior to gavage of 2.4 g glucose/kg body weight. Blood was
collected from the tail vein 4min after gavage into tubes with EDTA
and DPP-IV inhibitor (Millipore) and plasma separated by centrifuga-
tion. GLP-1 concentrations were measured using the active GLP-1 v.2
kit (Meso Scale Discovery, sensitivity 0.12 pg/ml, 31% cross-reactivity
to GLP-1 (7–37) and 0.1% to GLP-1 (9–36) amide). All experiments
were performed with male mice, HFD was begun around 8 weeks of
age.
2.2.3. VSG and sham surgery
For the surgery, mice were housed 2–3 per cage and had been on
HFD for 19–22 weeks. 4 days prior to surgery, mice were oﬀered a
highly viscous semi-solid porridge meal made of oat ﬂakes cooked with
water for 2 h to expose the mice to the unfamiliar taste and texture. The
last 3 days prior to surgery, mice had the choice between HFD and chow
and 2 h prior to surgery food was withdrawn. A broad-spectrum anti-
biotic enroﬂoxacin (10mg/kg, Baytril 2.5%, Bayer) and the analgesic
caprofen (5mg/kg, Norocarp, UFAMED) were administered sub-
cutaneously 2 and 1 h(s) prior to surgery, respectively. All surgeries
were performed under aseptic conditions. After induction of anaes-
thesia with isoﬂurane (Isoﬂo, Zoetis Schweiz GmbH), an upper midline
laparotomy was performed over a length of 1.5 cm to the xiphoid car-
tilage and a self-retaining retractor was placed. The liver was gently
retracted and the stomach freed by cutting the perigastric ligaments,
and all branches of the gastroepiploic vessels were carefully ligated and
cut close to the greater curvature of the stomach. For the vertical sleeve
gastrectomy (VSG), a tubular sleeve was created by applying a titanium
clip (LIGACLIP, Johnson and Johnson) on the stomach from 3mm
proximal to the pylorus, to the gastroesophageal junction (Angle of His)
always leaving the same stomach volume. The greater curvature was
dissected along the clip aiming for a resection of over 75% of gastric
volume including the complete fundus. 4–6 single stitches with 8-0
polyamid suture (Johnson and Johnson) were applied around the clip
for additional ﬁxation. After relocating the gastric sleeve, the lapar-
otomy was closed by continuous muscle and skin suture (6-0 Vicryl,
Johnson and Johnson). The procedure for the sham surgery was similar
to VSG except a small titanium clip (B9180, Vitalitec) was applied at
the greater curvature, leading to a restriction of less than 10% of gastric
volume. After the surgical procedure, animals promptly emerged from
anaesthesia and were returned to their home cage, which was placed on
a heating pad for the ﬁrst night. Mice were oﬀered porridge for around
24 h and switched back to HFD thereafter. Antibiotics were given for
one and analgesics for 3 postoperative days.
2.3. Immunoﬂuorescence
9 μm cryo-sections were ﬁxed with 4% paraformaldehyde and
permeablised with triton X-100, before blocking with donkey serum.
Sections were incubated overnight with primary antibodies targeting
GFP (ab5450, Abcam) and GLP-1 (sc-7782, Santa Cruz), before in-
cubation with ﬂuorophore tagged secondary antibodies. Control sec-
tions were stained with secondary antisera alone.
2.4. Puriﬁcation of L cells by FACS and RNA extraction
For FACS puriﬁcation of L cells, mice were sacriﬁced with CO2 and
the colon and ileum (the distal half of the SI) were washed in PBS on
ice. Gut pieces were cut open longitudinally and incubated in successive
tubes of PBS with 1.5mM EDTA and 0.5 mM DTT with rocking at 37 ⁰C,
and cells were released by agitation at the end of each incubation. The
ﬁrst fraction was disposed of, and the remainder stored as a pellet on ice
before combining and washing in PBS. Single cell suspensions were
sorted by ﬂow cytometry using side scatter, forward scatter, pulse
K.A. Rollins et al. Peptides 113 (2019) 22–34
23
width and DAPI intensity gates to exclude debris, aggregates and dead
cells, then L cells and epithelial cells were selected based on GFP (FITC)
intensity. Cells were sorted directly into lysis buﬀer and total RNA was
isolated using the RNeasy Plus Micro kit (Qiagen).
2.5. Quantitative RT-PCR
cDNA was synthesised using the high-capacity cDNA reverse
transcription kit (Applied Biosystems) and used for RT-qPCR reactions
using FAST SYBR green. Target gene expression was compared to that
of gapdh and 36B4 from the same sample and then L cells compared to
epithelial cells from the same mouse using the 2−ΔΔCt method.
2.6. Transcriptome sequencing
10 ng of total RNA was converted to cDNA using the Ovation RNA-
Fig. 1. Generation and validation of the gcg-DTR-eGFP reporter mouse and L cell puriﬁcation. (A) Schematic representation of the targeting construct used to
generate the gcg-DTR-eGFP mouse strain. (B) Co-localisation of GFP and GLP-1 by immunoﬂuorescence in the ileum (23 week chow diet mouse). Representative plots
of the gates used to sort colonic (C) and ileal (D) L cells and epithelial cells from all live single cells based on GFP intensity. Previously, dead cells were excluded based
on high DAPI intensity and aggregates and debris excluded based on side scatter and forward scatter. (E) GFP vs. APC (empty channel) plot of sorted colonic epithelial
and L cells. (F) Quantiﬁcation of known L cell enriched genes by qPCR in sorted colonic L cells, mean ± SEM shown, n= 3.
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Seq System V2 (NuGEN Technologies), which provides coverage of non-
coding (ncRNAs) and non-polyadenylated RNA transcripts in addition
to protein-coding mRNAs, while reducing ribosomal RNA conversion to
cDNA. Libraries were generated according to recommended procedures,
using the Illumina TruSeq methods. Sequencing was carried out using
the Illumina HiSeq 2000 system according to Illumina protocols as 85
bp, single reads and 7 bases index read. The raw reads were ﬁrst
cleaned by removing reads with low quality (phred quality< 20) using
Trimmomatic [28]. Sequence alignment of the resulting high-quality
reads to the Mus musculus reference genome (build GRCm38.p5) and
quantiﬁcation of gene level expression (Ensembl release 89) was carried
out using RSEM (Version 1.3.0) [29]. One colonic chow sample was
excluded from further analysis due to having<5 million reads map-
ping to exonic regions. A high proportion of rRNA reads were observed
in all samples due to the methods used (typically 40–60%), but the
large number of reads per sample ensured a suﬃcient depth of se-
quencing.
To detect diﬀerentially expressed genes we applied the count based
negative binomial model implemented in the software package EdgeR
(R version: 3.4.0, EdgeR version: 3.18.1) [30]. Multiple testing cor-
rection to calculate the false discovery rate (fdr) was performed using
the Benjamini and Hochberg method. Heatmaps and sample clustering
are based on EdgeR normalized values (TMM method). No batch eﬀect
was seen when comparing samples from the two experiments and se-
quencing runs (HFD / chow and VSG / sham). Sequence data that
support this study have been deposited in European Nucleotide Archive
(ENA) with the primary accession code PRJEB23754.
2.7. Sequencing data analysis
Diﬀerentially expressed genes were deﬁned as expressed genes,
those with a normalized count> 20 in at least half of the samples in at
least one of the conditions in the comparison, with an absolute log2
ratio> 1 and an fdr of less than 5%. Gene ontology (GO) enrichment
analysis (terms deﬁned by the GO Consortium, http://www.
geneontology.org/) was performed using GOrilla (Gene Ontology
enRIchment anaLysis and visuaLizAtion tool) [31,32], comparing an
unranked list of diﬀerentially expressed genes against a background of
genes expressed in the relevant comparisons. KEGG (Kyoto En-
cyclopaedia of Genes and Genomes) pathway enrichment analysis was
performed using DAVID 6.8 [33,34], again by comparing an unranked
list of diﬀerentially expressed genes against a background of expressed
genes (pathway names deﬁned in the KEGG pathway database, https://
www.genome.jp/kegg/pathway.html).
2.8. Nutrient stimulation of primary mixed cultures
Mixed primary cultures were prepared from the colon and distal
most 12 cm of the SI as published [35]. Brieﬂy, tissues were harvested
and washed in L-15 on ice, the muscle layer removed by dissection, and
the remaining mucosa and submucosa were digested in successive in-
cubations of collagenase XI. Harvested crypts were plated on matrigel
coated 24 well plates and left to recover overnight. Cells were washed
and stimulated for 2 h in a salt bath solution (138mM NaCl, 4.5mM
KCl, 4.2 mM NaHCO3, 1.2mM Na2HPO4, 2.5mM CaCl2, 1.2 mM MgCl2,
10 mM Hepes pH 7.4, 0.1% fatty acid free BSA). Test compounds
(glucose, arginine-vasopressin acetate or glycyl-sarcosine) and DPP-IV
inhibitor (Millipore) were added for the stimulation. The supernatant
was harvested, ﬂoating cells removed by pelleting, and the cultured
cells lysed (50mM Tris pH 7.4, 150mM NaCl, 1% IGEPAL-CA 630,
0.5% deoxycholic acid, protease and DPP-IV inhibitors). Samples were
stored at -80 ⁰C before active GLP-1 concentrations were measured with
the active GLP-1 v.2 kit (Meso Scale Discovery, sensitivity 0.12 pg/ml,
31% cross-reactivity to GLP-1 (7–37) and 0.1% to GLP-1 (9–36) amide).
2.9. Statistics
Data was analysed and statistical analyses performed using Graph
Pad Prism 7.0.3 and R x64 3.4.2, applying t-tests with Welch’s correc-
tion for non-equal variances and correcting for multiple testing using
Bonferroni correction where relevant. Results are presented as
mean ± SEM (standard error of the mean). A p-value<0.05 was
considered signiﬁcant.
3. Results
3.1. The gcg-DTR-eGFP reporter mouse can be used to isolate a population
of gcg-expressing (L) cells
We generated the gcg-DTR-eGFP mouse in which all L cells, here
deﬁned as gcg-expressing cells, are ﬂuorescently labelled (the construct
used is depicted in Fig. 1A). The speciﬁcity of GFP expression within the
intestine was conﬁrmed by immunoﬂuorescence which showed co-
staining of GFP and GLP-1 in cells with typical L cell morphology
(Fig. 1B). The co-expression of DTR enables the speciﬁc ablation of
these cells using diphtheria toxin, which is the subject of further studies
not included here.
The gcg-DTR-eGFP reporter mouse was used to isolate L cells and the
surrounding epithelial cells by FACS. Cells isolated from the ileum and
colon were gated for live cells using DAPI, debris and aggregates were
excluded based on side scatter and forward scatter, and ﬁnally epi-
thelial and L cells were selected based on GFP intensity using a wild
type control to determine the gating (Fig. 1C and D). GFP signal spe-
ciﬁcity was conﬁrmed by the absence of high autoﬂuorescence in the
empty APC channel (Fig. 1E). As expected, only a low proportion of
total cells were GFP positive, with a higher proportion observed in the
colon than the ileum. L cells are classically deﬁned as secreting GLP-1
and PYY, encoded by gcg and pyy respectively whose expression was
strongly enriched in puriﬁed L cells compared to epithelial cells, 700-
fold for gcg, conﬁrming the sorting speciﬁcity (Fig. 1F). Similarly, the
KATP-channel subunit genes kir6.2 and sur1, the sodium-coupled glucose
transporter sglt1, and the bile acid receptor gpbar1 (TGR5), which have
all previously been shown to be L cell enriched [36], were also enriched
here (Fig. 1F).
3.2. Global sequencing analysis conﬁrms overlap of enteroendocrine
hormone expression, and shows large diﬀerences between tissues
To determine the eﬀect of high fat diet (HFD) and vertical sleeve
gastrectomy (VSG) on the L cell transcriptome, male gcg-DTR-eGFP
mice were placed on a high fat or chow diet, or HFD fed mice under-
went VSG or sham surgery. As expected, mice on HFD compared to
chow diet showed increased body weight (Fig. 2A), fasting blood glu-
cose and a blunted response to insulin in an insulin tolerance test (ITT,
Fig. 2B). The slight increase in blood glucose at 15min in the ITT due to
stress was only seen in the HFD group. Separately, gcg-DTR-eGFP mice
which had been on HFD and developed insulin resistance were divided
into matched groups for sham or VSG surgery, in which the greater
curvature of the stomach was removed to leave a tubular stomach (full
details of the surgical procedure are outlined in 2.2.3). VSG resulted in
signiﬁcant body weight loss compared to sham (Fig. 2C), due to loss of
fat but not lean mass (Fig. 2D). Food intake was reduced in VSG mice
compared to shams for the entire 3 week follow-up period (Fig. 2E).
VSG mice also showed improved glucose tolerance in a mixed meal
tolerance test (intragastric gavage of Ensure plus liquid diet), with a
faster clearance of glucose after reaching the same peak at 15min
(Fig. 2F). In a separate and independent cohort, VSG increased plasma
GLP-1 concentrations following a glucose gavage 5 weeks post-surgery
(Fig. 2G).
The colon and ileum of chow, HFD, sham and VSG treated gcg-DTR-
eGFP mice were harvested and L cells, gcg-positive, (chow / HFD, n=5,
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16 weeks of diet) or L cells and epithelial cells, gcg-negative, (sham /
VSG, n= 7, around 20 weeks pre-surgical HFD and 22–29 days post-
surgery) were puriﬁed by FACS. No signiﬁcant diﬀerences were ob-
served in the number of L cells isolated in HFD vs. chow, or in the
number or proportion of L cells in VSG vs. sham (Supplementary
Information Fig. 1). Extracted RNA was used for bulk transcriptome
sequencing to determine widespread and consistent changes in the L
cell transcriptome in response to HFD or VSG. Cells from individual
mice were puriﬁed and sequenced as separate samples. The sorting
speciﬁcity of the sequenced samples was conﬁrmed by the enrichment
of gcg (Fig. 3A) and pyy (Fig. 3B) in colonic L cells compared to epi-
thelial cells in both the VSG and sham cohorts. gcg was also signiﬁcantly
enriched in ileal L cells and pyy showed a strong trend towards L cell
enrichment. Epithelial cells were not sorted from the HFD and chow
cohorts, but gcg and pyy are in the top 60 expressed genes in all L cell
cohorts (Fig. 3C). Other enteroendocrine hormones such as cck (Cho-
lecystokinin), nts (Neurotensin), sct (Secretin) and insl5 (Insulin-like 5)
are also amongst the highest expressed genes in L cells (Fig. 3C).
Multidimensional scaling (MDS) of all 75 sequenced samples shows
separation by tissue (colon vs. ileum) along the ﬁrst dimension, and by
cell type (epithelial vs. L cell) along the second dimension (Fig. 3D).
This indicates that there are large diﬀerences in the L cell transcriptome
along the GI tract with L cells clustering closer to their surrounding
epithelial cells than L cells from other intestinal locations, particularly
in the ileum. Nevertheless, the L cell retains some unique transcrip-
tional characteristics (see section 3.4) which distinguish L cells from the
average gut epithelial cell. No clear separation is seen between HFD and
chow or VSG and sham samples.
3.3. The metabolic state does not widely eﬀect the L cell transcriptome
A clustered heatmap of high variance genes from the HFD and chow
L cells shows separation by tissue, but not by diet (Fig. 4A). To de-
termine the eﬀect of HFD on the L cell transcriptome, diﬀerentially
expressed (DE) genes were identiﬁed for the HFD vs. chow comparison
separately in the colon and ileum (Fig. 4B, genes listed in Supplemen-
tary Information Table 2). As indicated by the heat map, only a small
number of DE genes were identiﬁed, none of which were DE in both
tissues, showing that there is no consistent regulation of the general L
cell transcriptome by chronic HFD. However, no DE genes being simi-
larly regulated in both tissues may be due to over half of these diet
regulated genes being tissue enriched in at least one ileum vs. colon
comparison (Fig. 4C, L-TissDEall genes deﬁned in Section 3.4). To de-
termine the biological consequences of these changes following HFD,
gene ontology (GO) biological process term enrichment was performed,
comparing all DE genes in both tissues to a background of genes ex-
pressed in at least one HFD vs. chow comparison. This revealed that
diet eﬀected genes are primarily involved in immune related processes
(Fig. 4D).
Similarly, a heatmap of all L cell VSG and sham samples shows se-
paration by tissue but not surgery (Fig. 4E). The comparison of VSG vs.
sham was calculated for each tissue but no genes reached the diﬀer-
ential expression cut-oﬀ. To determine if this was due to large variation
in weight loss of the sham cohort, probably due to some sham mice
receiving a small reduction in stomach volume, VSG samples were
compared to the three heaviest shams only, but still no DE genes were
identiﬁed.
3.4. Large diﬀerences are seen between ileal and colonic L cell
transcriptomes
As indicated by the MDS analysis (Fig. 3D), a heatmap clearly shows
that the majority of the top variance L cell genes are diﬀerentially ex-
pressed between tissues (Fig. 5A). An ileum vs. colon comparison was
made separately for each metabolic condition (HFD, chow, VSG and
sham), identifying a large number of DE genes in all cases (838 – 1 600)
with similar numbers of colonic and ileal enriched genes (Fig. 5B). The
overlap between the DE genes identiﬁed shows many genes are
Fig. 2. Metabolic characterisation of the HFD/chow and VSG/sham cohorts. (A) Body weight at the time of L cell isolation by FACS, and (B) blood glucose following
i.p. insulin injection of the HFD and chow mice used for L cell sequencing, n= 3 - 5. (C) % of initial body weight, (D) total, lean and fat mass 21 days post-surgery, (E)
cumulative food intake per 5 days, and (F) blood glucose during a mixed meal tolerance test (gavage of Ensure) of the VSG and sham mice used for sequencing. (G)
Active GLP-1 concentration in plasma following glucose gavage in an independent VSG cohort. n= 7 for all VSG/sham experiments, except (G) where n=5 for sham
and 8 for VSG. Mean ± SEM shown, signiﬁcance calculated by Welch two sample t-test with multiple testing correction by Bonferroni method where relevant. * =
p < 0.05, ** = p< 0.01, *** = p< 0.001.
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Fig. 3. Large tissue diﬀerences are seen in the whole L cell transcriptome. Fragments per kilobase of transcript per million mapped reads (fpkm) of (A) gcg and (B) pyy
in sequenced L and epithelial cells (n= 7). Mean ± SEM shown, signiﬁcance calculated by Welch two sample t-test with multiple testing correction by Bonferroni
method, * = p< 0.05, ** = p< 0.01, *** = p < 0.001. (C) The rank of genes encoding enteroendocrine hormones in all L cell cohorts when all genes are ordered
by average fpkm. (D) Multidimensional scaling of all 75 samples used for transcriptome analysis.
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consistently tissue enriched, with 293 deﬁned as DE genes in all 4
comparisons and an additional 313 being regulated in 3 of the 4 me-
tabolic conditions (L-TissDEconst, Fig. 5C, genes listed in Supplementary
Information Table 3). In all cases, these 606 consistently regulated
genes are enriched in the same tissue in all signiﬁcant comparisons,
showing the diﬀerences seen are robust and consistent across the two
independent experiments. The 2 674 genes DE in at least one metabolic
condition are deﬁned as L-TissDEall.
GO enrichment analysis of the L-TissDEconst genes (compared to a
background of genes expressed in at least 3 of the 4 comparisons), re-
vealed a high enrichment in genes involved in transport (Fig. 5D), and
similarly KEGG pathway analysis showed the largest enrichment in
protein and fat digestion and absorption (Fig. 5E). Separate analyses of
genes enriched in the ileum and colon indicated that the observed
Fig. 4. The eﬀect of HFD induced insulin resistance and VSG surgery on the L cell transcriptome. (A) Heatmap of top 1000 high variance genes across all HFD and
chow samples, with genes and samples ordered by hierarchical clustering. (B) Number of DE genes and their direction of regulation for the HFD vs. chow comparison.
(C) Overlap of diet regulated genes from the ileum and colon and all genes enriched in at least one colon vs. ileum comparison. (D) Top 10 enriched GO process terms
for all DE genes in the HFD vs. chow comparison. (E) Heatmap of top 1000 high variance genes across all VSG and sham L cell samples, with genes and samples
ordered by hierarchical clustering.
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enrichments were driven by ileal enriched genes (Supplementary In-
formation Fig. 2). Thus, ileal L cells are enriched for dietary nutrient
transport genes, in line with the increased presence of luminal nutrients
in this region. In addition, several enteroendocrine hormones are dif-
ferentially expressed between tissues with gcg, pyy, ppy and insl5 en-
riched in the colon in at least one comparison, and gip in the ileum. The
degree of enrichment varies, with gcg being only slightly enriched
compared to insl5 which is almost speciﬁc to the colonic L cell.
3.5. Epithelial cells diﬀer between the colon and ileum in a similar way to L
cells, with L cells being deﬁned by a small distinct subset of genes
As L cell tissue diﬀerences are primarily due to genes involved in
nutrient transport, and the MDS analysis (Fig. 3D) indicated similarities
Fig. 5. Comparison of colonic and ileal L cell transcriptomes. (A) Heatmap of top 500 high variance genes across all L cell samples, genes arranged by hierarchical
clustering and samples ordered by condition. (B) Number of DE genes and their direction of regulation for ileum vs. colon comparisons. (C) Overlap of diﬀerentially
expressed genes per condition. The purple squares highlight the consistently regulated genes used for further enrichment analyses. (D) GO process enrichment and (E)
KEGG pathway enrichment of L-TissDEconst genes.
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to epithelial cells, we investigated to what extent the tissue diﬀerences
in L cells recapitulate diﬀerences in the surrounding epithelium and
which are speciﬁc to the L cell. Clustering of the top variance genes
shows many genes are similarly tissue enriched in epithelial and L cells,
but a subset of genes are diﬀerentially expressed between L cells and
epithelial cells from the same tissue (yellow cluster, Fig. 6A). DE genes
were deﬁned for the ileum vs. colon comparison of epithelial cells from
VSG and sham, and again a large number of genes (1 142 – 1 288) were
identiﬁed with similar numbers regulated in each direction (Fig. 6B).
The overlap between the VSG and sham comparisons gives 754 con-
sistently tissue enriched genes, only one of which is enriched in dif-
ferent tissues in each condition (EpiTissDEconst, Fig. 6C, genes listed in
Fig. 6. L cell tissue speciﬁcity in the context of epithelial cells. (A) Heatmap of top 500 high variance genes in VSG/sham L cell and epithelial cell samples, genes
arranged by hierarchical clustering and samples ordered by condition. (B) Number of DE genes and their direction of regulation for the ileum vs. colon comparison of
epithelial cells. (C) Overlap of these DE genes, the consistently tissue enriched genes used for enrichment analyses are highlighted in the purple box. (D) Overlap of
consistently tissue enriched genes in L cells (L-TissDEconst) and epithelial cells (EpiTissDEconst). (E) GO process enrichment of the EpiTissDEconst genes. (F) Number of
DE genes and their direction of regulation for the L cell vs. epithelial cell comparison. (G) GO process enrichment of all L cell enriched genes. (H) Overlap of L cell
enriched and tissue enriched genes (L-TissDEall).
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Supplementary Information Table 4). Together, this conﬁrms that epi-
thelial cells also diﬀer widely and consistently between the ileum and
colon.
There is a large overlap between the L-TissDEconst and EpiTissDEconst
genes (Fig. 6D), with all the overlapping genes being enriched in the
same tissue. Additionally, GO process term enrichment of EpiTissDEconst
genes shows the greatest enrichment in terms associated with transport
similarly to the L cell (Figs. 5D and 6 E), and conﬁrming that the tissue
diﬀerences in the L cell transcriptome largely reﬂect the local en-
vironment with L cells recapitulating many properties of the sur-
rounding epithelium. Again, the enrichment in GO terms associated
with transport is driven by ileal enriched genes, but, in contrast to L
cells, the colonic enriched genes also show a slight enrichment in
transport associated terms (Supplementary Information Fig. 3), re-
ﬂecting the specialised role of enterocytes which constitute the majority
of intestinal epithelial cells.
To identify which genes distinguish L cells from the surrounding
epithelium, DE genes were identiﬁed for the L cell vs. epithelial com-
parison for the VSG and sham cohorts per tissue (Fig. 6F). Many DE
genes were identiﬁed showing that L cells are transcriptionally distinct
from the majority of intestinal epithelial cells. A larger number of DE
genes were identiﬁed from the colonic samples, showing that colonic L
cells are more distinct from the surrounding cells, as indicated by the
MDS plot in Fig. 3D. GO process term enrichment of the genes L cell
enriched in at least one comparison (green bars in Fig. 6F) shows L cells
are enriched in genes involved in ion transport, and the regulation of
secretion and signalling compared to the surrounding epithelial cells
(Fig. 6G). To determine which L cell enriched genes are diﬀerentially
expressed between tissues, the overlap between these L cell enriched
genes and L-TissDEall genes was determined. Around half of the L cell
enriched genes are tissue enriched (Fig. 6H, genes listed in Supple-
mentary Information Table 5), showing that even the genes which de-
ﬁne an L cell vary along the length of the gut and that not all the tissue
speciﬁcity of L cells is due to similarities with the local epithelial
transcriptome. 306 of the 376 tissue enriched L cell enriched genes are
colonically enriched, again conﬁrming that colonic L cells are more
distinct from the epithelium. Selected L cell enriched tissue enriched
genes are listed in Table 1. In contrast, the 365 L cell enriched genes
that are not tissue speciﬁc can be used as more generally applicable
markers for L cells (genes listed in Supplementary Information Table 6),
although we cannot rule out the expression of these in small numbers of
non-L cells.
3.6. L cells from diﬀerent regions diﬀer in sensitivity to GLP-1 secretagogues
To conﬁrm that these diﬀerences in nutrient transporter and hor-
mone receptor expression between the ileum and colon aﬀect regula-
tion of GLP-1 secretion from L cells, primary mixed cultures of crypts
isolated from the ileum and colon were stimulated and the proportion
of GLP-1 secreted determined. Slc5a1, encoding the sodium-glucose
transporter SGLT1, and slc15a1, encoding the peptide transporter
PEPT1, were identiﬁed as enriched in the ileum in L cells from all
metabolic conditions. In contrast, avpr1b, the receptor for vasopressin,
was identiﬁed as enriched in the colon in two comparisons. Fig. 7A
shows the fpkms of these genes in L cells, all of which have been shown
to be involved in the regulation of GLP-1 secretion [36–38]. Colonic
crypts secreted a greater proportion of their GLP-1 content than ileal
cells under unstimulated conditions, did not respond to stimulation by
glucose, and were strongly simulated by arginine-vasopressin. In con-
trast, ileal crypts were stimulated by glucose and only showed a mild
induction by arginine-vasopressin (Fig. 7B). The non-hydrolysable di-
peptide glycyl-sarcosine (gly-sar), which acts through PEPT1, also sti-
mulates ileal cells to a greater extent as predicted. Taken together, this
conﬁrms that ileal and colonic L cells respond diﬀerently to physiolo-
gical stimuli.
4. Discussion
The L cell and GLP-1 are established drug targets for the treatment
of T2DM, but both L cell heterogeneity and the changes L cells undergo
during the development of diabetes and its resolution following bar-
iatric surgery are not well understood. We report the development of
the gcg-DTR-eGFP mouse line, a L cell reporter line generated in-
dependently of the gcg-Venus mouse published by Reimann et al. [36],
and an alternative cell isolation procedure which is speciﬁc for epi-
thelial cells. This enabled the transcriptomic characterisation by RNA
sequencing of FACS isolated L cells, here deﬁned as gcg-expressing cells,
and the surrounding epithelial cells after HFD (L cells only) and VSG.
We focused on the changes following HFD and VSG, the diﬀerences
between L cells from diﬀerent tissues (ileum and colon), and the simi-
larities and diﬀerences between L cells and the surrounding epithelium.
As expected, HFD led to increased body weight, elevated fasting
blood glucose and the development of insulin resistance, with VSG re-
sulting in body fat loss, improved glucose tolerance and increased
postprandial circulating GLP-1. As the HFD and VSG experiments were
not performed in parallel the metabolic characteristics cannot be di-
rectly compared, so an ITT was not performed in the VSG cohort to
minimise stress and enable the characterisation of the L cell tran-
scriptome at a relatively early timepoint post-surgery. Given the phe-
notypes we observed, we were surprised that the L cell transcriptome
showed only small changes after HFD and was not signiﬁcantly altered
following VSG. There was no signiﬁcant regulation of gcg or proteins
known to be involved in the regulation and secretion of GLP-1, so, in
our hands, transcriptional changes in ileal and colonic L cells cannot
explain the inﬂuence of HFD or VSG on GLP-1 secretion. As we per-
formed bulk sequencing, changes in a subset of L cells in response to
HFD or VSG cannot be ruled out, but to contribute to the observed
physiological eﬀects we would expect a widespread and consistent re-
sponse in the majority of L cells, or at least an eﬀect strong enough to
inﬂuence bulk results. Our ﬁndings are in contrast to the work of
Richards et al. who describe reduced expression of L cell speciﬁc genes
following HFD [12], possibly as they used the whole SI in their long
term experiments or due to methodological diﬀerences such as tissue
preparation methods and time of day of harvest. However, as here we
sequenced mice with elevated fasting blood glucose, our ﬁndings are in
line with Dusaulcy et al. who observed that L cells from hyperglycaemic
HFD mice have a molecular footprint similar to low fat diet mice, in
contrast to normoglycaemic HFD mice [10].
DE genes after HFD were enriched for those associated with immune
related processes. Previously, the L cell has been shown to respond to
and contribute to immune activation and gut inﬂammation.
Lipopolysaccharide (LPS) administration and manipulation of gut bar-
rier integrity trigger GLP-1 secretion [39], GLP-2 enhances intestinal
barrier function [40,41], and GLP-1 receptors regulate intestinal
Table 1
Hormones, transporters and GPCRs from the 376L cell enriched tissue enriched
genes.
Hormones GPCRs Transporters
Insl5 Avpr1b Slc8a1 Scn3a Rims2
Ppy Gprc5c Kcnk3 Pea15a Slc12a2
Gcg Adgrl1 Abcc1 Kcnh2 Cacna1c
Pyy Chml Slco3a1 Abcc8 Asic2
Gpr119 Slc29a4 Kif5c Nup210
Sstr5 Stard5 Kcnb1 Gga2
Hcar2 Slc6a19 Cadps Atp1a3
Celsr3 Itpr1 Hap1 Apoe
Agtr1a Esyt1 Grik5 Dync1i1
Cmklr1 Stxbp1 Scg5 Gpm6b
P2ry13 Tmed8 Ap3b2 Mcoln3
Gpr179 Sv2c Ryr3 Ramp2
Lrrc8c
K.A. Rollins et al. Peptides 113 (2019) 22–34
31
epithelial lymphocytes [42]. Here, several major histocompatibility
complex (MHC) genes were downregulated by HFD, such as H2-K1 in
the colon, indicating that antigen presentation by the L cell, a key
sensor of luminal content, is altered by HFD. As L cells are able to sense
directly the external and immunotolerant environment of the intestinal
lumen, this regulation of MHC genes by HFD may contribute to the
chronic inﬂammation commonly associated with obesity.
The absence of signiﬁcant regulation of the L cell transcriptome
following VSG indicates that, under the measured conditions, changes
in GLP-1 secretion occur without a major resetting of the transcriptional
proﬁle of distal L cells. Thus, if VSG regulates GLP-1 secretion from
these cells it does so at the protein level, or elevated GLP-1 secretion
simply occurs due to changes in luminal nutrient content and absorp-
tion following VSG resulting from increased rates of gastric emptying
and intestinal transit [43]. Alternatively, altered circulating GLP-1 may
be due to transcriptional changes in proximal L cells or, more unlikely,
pancreatic α-cells. To date, no comparable data on the L cell tran-
scriptome following bariatric surgery has been published, so to conﬁrm
the general applicability of our ﬁndings experiments including the
proximal intestine, additional time-points post-surgery and diﬀerent
surgical procedures such as Roux-en-Y gastric bypass are required.
In contrast to the eﬀects of diet and surgery, large diﬀerences were
observed between ileal and colonic cells, which were fairly consistent
across the two independent experiments. Previously, selected L cell
related genes have been shown to be diﬀerentially expressed along the
length of the gut [3,36,44], but here we have performed an analysis of
the complete transcriptome, and considered L cell tissue diﬀerences in
the context of the surrounding epithelium. Additionally, we identiﬁed a
large number of genes enriched in L cells compared to the general
epithelium, both tissue enriched and those which are not diﬀerentially
expressed between tissues, which could be used as alternative L cell or
enteroendocrine cell (EEC) markers. Both MDS analysis and the num-
bers of DE genes indicated that L cells are transcriptionally more similar
to their surrounding epithelial cells than to L cells from a diﬀerent re-
gion of the gut. As per the classic deﬁnition of an L cell, FACS puriﬁed L
cells showed high expression and enrichment of both gcg and pyy.
Several additional hormones were also highly expressed, including cck,
nts and sct, conﬁrming in a further mouse model the widespread overlap
of enteroendocrine hormone expression in L cells as previously reported
[3,45–47]. Enteroendocrine hormones display expression gradients
along the GI tract [1] which is classically due to diﬀerent gradients of
each enteroendocrine cell type. However, we observe that several
hormones are diﬀerentially expressed within L cells, such as the colonic
enrichment of gcg, pyy and insl5 and ileal enrichment of gip which is in
agreement with the work of Habib et al. [3], except INSL5 was not
included in their study. A trend towards gcg enrichment in colonic L
cells was also observed by Suzuki et al. [44], but they observed in-
creased pyy expression in SI cells in contrast to our work and that of
Habib et al. Here, the expression of pcsk1 or pcsk2 was not signiﬁcantly
diﬀerent between tissues, suggesting no large diﬀerences in the pro-
cessing of Preproglucagon.
L cells secrete hormones in response to luminal nutrients sensed by
GPCRs or through electrogenic transporters [48]. GO process and KEGG
pathway enrichment analyses showed that the transcriptomic diﬀer-
ences between ileal and colonic L cells are primarily driven by ileal
enrichment of genes involved in nutrient transport and metabolism,
including several proteins known to regulate the L cell response to
nutrients. For example, slc5a1 and slc15a1 are involved in the L cell
response to glucose and di/tripeptides respectively [36,37] and are
consistently ileal enriched. Published data showed that glucose stimu-
lated GLP-1 responses are increased in the rat SI compared to the colon
[49] and here we conﬁrmed that ileal L cells secrete GLP-1 in response
to glucose and the non-hydrolysable gly-sar dipeptide to a greater ex-
tent than colonic cells, as predicted by the diﬀerential gene expression.
The absence of regulation by dietary nutrients of GLP-1 secretion by
colonic L cells has also been indicated by recent work showing the co-
secretion and thus co-regulation of GLP-1, PYY and INSL5 secretion
from colonic L cells, despite circulating levels of INSL5 being increased
upon caloric restriction in contrast to postprandial elevations in GLP-1
[50]. Although we only conﬁrmed the eﬀect of glucose and gly-sar on
GLP-1 secretion in primary cells, the transcriptomic data, distribution of
dietary nutrients in the GI tract and recent publications indicate that
there are widespread tissue diﬀerences in the response to dietary nu-
trients such that ileal L cells contribute more to postprandial GLP-1
secretion than colonic cells. In contrast, our gene expression data in-
dicates a role of colonic cells in the response to non-dietary luminal
metabolites. ﬀar2 (GPCR43), which induces GLP-1 secretion in re-
sponse to the short chain fatty acids produced by microbiota from
dietary ﬁbre in the distal lumen [51,52], is enriched in the colon in one
cohort.
The potential of the L cell to respond to circulatory and not solely
luminal stimuli has recently been illustrated. Arginine vasopressin has
been shown to act through avpr1b in colonic L cells to induce GLP-1 and
PYY secretion, which may contribute to intestinal ﬂuid homeostasis as
PYY reduces colonic water and anion secretion [38], and GLP-1 has
been implicated in a putative gut-renal axis regulating postprandial
ﬂuid and electrolyte homeostasis [53]. We showed that arginine vaso-
pressin stimulated GLP-1 secretion from colonic cells to a greater extent
than ileal cells, likely due to the diﬀerential expression of avpr1b which
is enriched in the colon in the HFD and chow cohorts. We also observed
that colonic L cells basally secrete a greater proportion of their GLP-1.
Together, this indicates that the primary role of GLP-1 secretion by
Fig. 7. L cells respond diﬀerently to GLP-1 se-
cretagogues dependent on their location in the
GI tract. (A) Average fpkm of selected genes
from all L cell sequenced samples (chow, HFD,
sham, VSG), n=23 for colon and 24 for ileum.
Signiﬁcance calculated with Welch two sample
t-test adjusted for multiple testing with
Bonferroni correction, *** = p< 0.001. (B)
Active GLP-1 secreted normalised to GLP-1
content of well, ctrl (unstimulated) n=18 from
3 mice, glucose n=10 from 3 mice, gly-sar
n=11 from 3 mice, arginine vasopressin n=6
from 2 mice. Signiﬁcance calculated with Welch
two sample t-test, ** = p< 0.01, *** =
p< 0.001 for comparison to control from the
same tissue adjusted for multiple testing with
Bonferroni correction, a= p< 0.001 for com-
parison between ctrl from colon and ileum. In
all cases, mean ± SEM shown.
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colonic L cells is not the control of postprandial glucose homeostasis but
rather a contribution to basal levels of GLP-1 and other aspects of
homeostasis. Nevertheless, colonic L cells may contribute to glucose
homeostasis through the secretion of other hormones, for example the
colon speciﬁc INSL5 which promotes appetite and hepatic glucose
production during periods of energy deprivation [54,55]. In general,
our data indicates that L cells from diﬀerent regions of the GI tract
contribute diﬀerently to whole organism metabolism, by responding to
diﬀerent luminal metabolites, secreting diﬀerent hormones, and re-
acting with diﬀerent kinetics as metabolites arrive at diﬀerent times
post-ingestion.
Here we performed bulk RNA sequencing as the primary aim was to
identify the changes which occur following HFD and VSG in a con-
sistent manner across all L cells. However, to explore L cell hetero-
geneity in more detail, sequencing of single L cells is required and has
recently been used to highlight the transcriptional heterogeneity of L
cells within a single intestinal region. Glass et al. focused on gcg-ex-
pressing cells from the upper SI and classiﬁed L cells into three tran-
scriptional clusters each with a distinct proﬁle of hormone expression
[56], and Haber et al. performed clustering of all SI epithelial cells to
redeﬁne enteroendocrine cell types with both SILA and SIL-P cells ex-
pressing both pyy and gcg [57]. The tissue diﬀerences we observe sug-
gest that additional L cell / enteroendocrine transcriptional clusters
exist in the distal gut with the composition of the heterogeneous L cell
population changing along the gut axis. Furthermore, L cells have been
shown to alter their hormonal proﬁle as they migrate along the crypt-
villus axis [58], adding to the complexity of L cell heterogeneity. There
remains a requirement for a better understanding of this heterogeneity
along the GI tract and the subsequent development of a new EEC
classiﬁcation to reﬂect this. Clinically, this heterogeneity will have
implications on the eﬀects and eﬃcacy of novel anti-diabetic drugs, so
the speciﬁc transcriptome of the subset of L cells expressing target
proteins should be considered during drug development.
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